Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...
Since the dawn of the computer age, researchers have wrestled with two persistent challenges: how to store ever-increasing ...
The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...
Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...
DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
The biochips market is projected to expand from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, driven by a CAGR of 8 ...
Viral DNA that is usually dismissed when sequencing the human genome could help to uncover useful information about complex ...
Over the past decade, circulating tumor DNA (ctDNA) has emerged as one of the most transformative biomarkers in oncology, offering unprecedented ...
Particle therapy, including proton and carbon ion radiotherapy, represents a major advancement in cancer treatment due to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results